September 29, 2025

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 10% Upside Potential in the Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a robust market capitalization..

Solventum Corporation (SOLV) Stock Analysis: Healthcare Innovator with a 20.85% Upside Potential

Solventum Corporation (NASDAQ: SOLV), a key player in the healthcare sector, has captured the attention of investors with a promising 20.85% potential upside, making it a..

The Cooper Companies, Inc. (COO) Stock Analysis: Unlocking a 25% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find The Cooper Companies, Inc. (NYSE: COO) an attractive proposition. With its expansive reach in the medical instruments..

Amgen Inc. (AMGN) Stock Analysis: Evaluating a 14.17% Potential Upside Amid Strong Dividend Yields

Amgen Inc. (AMGN), a titan in the healthcare sector, operates within the drug manufacturing industry, a realm known for its robust growth potential and constant innovation...

Cencora, Inc. (COR) Stock Analysis: Exploring the 8.42% Upside Potential and Robust Dividend Strategy

Cencora, Inc. (COR), formerly known as AmerisourceBergen Corporation, is a formidable player in the healthcare sector’s medical distribution industry. With a market capitalization of $59.52 billion,..

Doximity, Inc. (DOCS) Stock Analysis: What Investors Should Know About Its Healthcare Tech Edge

Doximity, Inc. (NASDAQ: DOCS), a leading digital platform for medical professionals, stands at the intersection of healthcare and technology, offering a unique investment opportunity within the..

Medtronic plc. (MDT) Stock Analysis: Exploring Growth Potential Amid Strong Revenue Growth and Dividend Yield

Medtronic plc (NYSE: MDT), a leader in the medical devices industry, commands significant attention from investors due to its robust market position and steady performance metrics...

argenx SE (ARGX) Stock Analysis: Riding a 97.6% Revenue Growth Wave with a 14.91% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector, continues to capture investor attention with its innovative approach to treating autoimmune diseases. As a commercial-stage..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Promising 18.97% Upside in the Thriving Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX), a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is making waves among investors with..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Navigating a 20.80% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, has been attracting investor attention with a compelling potential upside of 20.80%. This..

Genmab A/S (GMAB) Stock Analysis: A 9.43% Potential Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) offers a compelling case. With its robust pipeline of antibody-based products targeting cancer and..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Unlocking a 30% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a key player in the healthcare sector, specializes in the manufacturing and distribution of generic and specialty medicines. With a market..

Tenet Healthcare Corporation (THC) Stock Analysis: Riding the Peak with Strategic Growth and Robust Investor Confidence

Investors and healthcare enthusiasts, take note: Tenet Healthcare Corporation (NYSE: THC) is catching the spotlight with its strategic growth initiatives and robust market performance. As of..

DaVita Inc. (DVA) Stock Analysis: Insights into Potential 17.35% Upside for Healthcare Investors

DaVita Inc. (NYSE: DVA), a leading provider of kidney dialysis services in the United States, is catching the attention of investors due to its notable potential..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 13% Potential Upside Amid Robust Oncology Innovations

Investors eyeing opportunities in the biotechnology sector should consider Exelixis, Inc. (EXEL), a prominent player in oncology with a market cap of $10.51 billion. Specializing in..

Illumina, Inc. (ILMN) Stock Analysis: A Deep Dive into Its 21% Potential Upside

Illumina, Inc. (NASDAQ: ILMN), a leading player in the healthcare sector’s diagnostics and research industry, has long been a cornerstone in the genomic analysis landscape. With..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Analysts See 78% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading player in the biotechnology sector, is capturing investor attention with its promising growth potential. Based in San Rafael, California,..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a 7.76% Potential Upside with Robust Diagnostics Portfolio

Hologic, Inc. (NASDAQ: HOLX), a stalwart in the healthcare sector, stands out with its focus on women’s health through diagnostic products, imaging systems, and surgical solutions...

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 47.68% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector specializing in innovative medical instruments and supplies, is capturing investor attention with a notable potential..

Quest Diagnostics (DGX) Stock Analysis: Navigating a Complex Healthcare Landscape with a Strong Market Position

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Search

Funds

September 29, 2025

Search

Funds

September 29, 2025

FTSE 100

Funds